Solara Active Pharma Sciences Initiates Transfer of Shares to IEPF for Unclaimed Dividend from FY 2018-19
Solara Active Pharma Sciences Limited has initiated procedures regarding shares pertaining to shareholders whose dividend payments from Financial Year 2018-19 remain unclaimed and unpaid. As per the rules governing such instances, these shares are liable for transfer to the Investor Education and Protection Fund (IEPF) Authority.The company announced that any equity shares related to dividends for FY 2018-19 that have not been claimed by shareholders for a consecutive period of seven years or more must be transferred to the IEPF Authority.
Shareholders who are in possession of these relevant shares are given until September 10, 2026, to claim the unpaid dividend amounts. If no claim is received by this deadline, the shares will subsequently be transferred to the IEPF Authority. The company has confirmed that after the specified date, no further claims for the unpaid dividend can be entertained.
The announcement also noted that subsequent to the transfer of these shares to the IEPF Authority, all future benefits, including any eventual dividends, that may accrue to these shares will be credited directly to the IEPF Authority.
SOLARA Stock Price Movement
Shares of Solara Active Pharma Sciences Limited slipped by 0.42% on Thursday, closing at ₹568.05 as trading activity concluded. The stock registered a total traded volume of 216,961 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.